Reverse transcriptase was purified from human immunodeficiency virus (HIV).
It has been demonstrated that a human retrovirus, human immunodeficiency virus (HIV), is the etiological agent of the acquired immune deficiency syndrome. Like all retroviruses, HIV contains an RNA-directed DNA polymerase (reverse transcriptase [RT] ), which catalyzes the synthesis of a double-stranded DNA copy of the viral RNA (22). In vitro, RT can copy natural heteropolymeric or synthetic homopolymeric RNA, DNA, or RNA-DNA primer-template combinations. It has been shown with crude preparations of HIV RT obtained from extracted virus pellets that this enzyme is dependent on the presence of the divalent cation Mg2+ for activity (3, (13) (14) (15) 18) , exhibits a preference for the artificial primer-template poly(rA)-oligo(dT)12_18 (14, 18) , and has a pH optimum of 7.6 to 8.0 (14, 18) .
Because the HIV RT is virus-encoded and is required for viral DNA synthesis, it is a good target for antiviral chemotherapy. In 1985, Mitsuya et al. (16) described the anti-HIV activity of 3'-azido-3'-deoxythymidine (N3dThd; azidothymidine; BW A509U). This agent, which selectively interacts with HIV RT, inhibits virus replication and blocks the cytopathic effect of HIV in vitro. It was also reported that N3dThd is converted to the mono-, di-, and triphosphate derivatives in uninfected and HIV-infected H9 cells (12) . The concentration of the triphosphate derivative (3'-azido-3'-deoxythymidine triphosphate [N3dTTP]) required to inhibit HIV RT by 50% was 1/100 of that required to inhibit cellular DNA polymerase a by 50% (12) . In another study, a Ki of 13 nM was calculated from a 50% inhibitory concentration for N3dTTP with purified HIV RT (5) .
The present study describes in detail the mechanism of inhibition of HIV RT by N3dTTP Inhibition of HIV RT and cellular DNA polymerases a and I by N3dTTP. The effects of N3dTTP on HIV RT and H9 cellular DNA polymerases a and P were studied. Because N3dTTP caused a time-dependent progressive decay in the rate of product formation by HIV RT (Fig. 1) , the initial velocities of reaction mixtures containing N3dTTP (Fig. 2) were analyzed by fitting all the data points to a first-order curve as described in Materials and Methods. N3dTTP competitively and potently inhibited the binding of dTTP to HIV RT for each primer-template. The Kms for dTTP and the Kis for N3dTTP for each of the three DNA polymerases are presented in Table 2 . Cellular DNA polymerases a and , were both significantly less sensitive to inhibition by N3dTTP.
Incorporation of [3H]N3dTMP. The ability of HIV RT to incorporate [3H]N3dTMP into poly(rA)-oligo(dT)12_18 was
determined in the absence of any competing nucleotides. N3dTTP served as an alternate substrate and was incorporated into a DNA primer as N3dTMP (Fig. 3) (Fig. 4) (Fig. 5) showed bands in identical positions, indicating that incorporation of N3dTMP into the newly synthesized DNA strands resulted in base-specific chain termination at the thymidine residues. DISCUSSION HIV RT was isolated from polyethylene glycol-precipitated virus by chromatography on DEAE-cellulose and phosphocellulose. The purified HIV RT exhibited a preference for magnesium over manganese, KCI over NaCl, and the artificial primer-template poly(rA)-oligo(dT)1218 over the other primer-templates tested. That the purified HIV RT preferred poly(rA)-oligo(dT)1218 as a primer-template was in contrast to results recently reported for the purified enzyme (5) in which primer-templates of various template-to-primer ratios were compared, but is in agreement with results obtained with extracts of purified virus as a source of enzyme. Thus, the present studies with purified enzyme confirmed the earlier results obtained with extracted virus.
N3dTTP was a potent competitive inhibitor of the HIV RT, with a Ki of 0.04 ,uM with poly(rA)-oligo(dT)1218 as the b Triton X-100-extracted virus pellet.
primer-template. This result was similar to a previously published value determined from a 50% inhibitory concentration (5) but 10-fold higher than that determined by using extracted virus as a source of enzyme (23 structure which is not necessarily the actual structure. While preliminary unpublished data suggest that N3dTTP does not inactivate HIV RT, the ability of N3dTMP-terminated primer-template to function decreased with incubation with HIV RT and N3dTTP, further supporting the conclusion that chain termination occurs. Finally, chain termination was demonstrated in vitro by a modification of the dideoxy sequencing method in which N3dTTP was shown to terminate the synthesis of DNA specifically at thymidine residues. These results are similar to those reported by Elwell et al. (7) with the Klenow fragment of Escherichia coli DNA polymerase I.
Our data indicate that N3dTTP is a selective and potent alternate substrate inhibitor of HIV RT that causes chain termination of the newly synthesized DNA chain. It may be either competitive inhibition, chain termination, or a combi- nation of both that is important to the antiviral activity of N3dThd.
